RxDoctor Payments Data

Richard Miller, DPM

Primary Podiatric Medicine · Charlotte, NCNPI 1194723809

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Koya Medical, Inc. at 24.4% of the total. Reporting peaked in 2022 at $1,167 and has fallen 97.6% since, to $28 in 2025.

$2,658in general payments, 2019–2025

Across 84 payments — averaging $31.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Koya Medical, Inc.$648
  • Stryker$500
  • Amgen$238
  • Sebela Pharmaceuticals Inc.$205
  • Convatec Inc.$126
  • Smith+Nephew$122
  • plus $821 from 21 others

What the payments were for

  • Food & beverage$2,658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,658 in reported general payments places this provider in the 70th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$111,288
Medicare patients
384
Services billed
1,774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin87$396
Diclofenac Sodium34$326
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav31$191
Meloxicam75$169
Terbinafine Hcl48$163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$144
Carvedilol16$95

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →